Phase I clinical trial of SGX 94 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2014
Price : $35 *
At a glance
- Drugs Dusquetide (Primary)
- Indications Mucositis
- Focus Adverse reactions; Pharmacokinetics
- 09 Apr 2014 New trial record
- 07 Apr 2014 SGX 94 showed safety in a completed phase I trial in healthy volunteers, according to a Soligenix media release.
- 12 Dec 2012 Soligenix acquired all rights to SGX 94, including preclinical and phase I data in healthy human volunteers, from the University of British Columbia, Canada, according to a Soligenix media release.